The (CAG)n tract of Machado-Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls

被引:18
|
作者
Bettencourt, Conceicao [1 ,2 ,3 ]
Santos, Cristina [1 ,2 ,4 ]
Montiel, Rafael [5 ]
Kay, Teresa [6 ]
Vasconcelos, Joao [7 ]
Maciel, Patricia [8 ]
Lima, Manuela [1 ,2 ,3 ]
机构
[1] Univ Azores, Ctr Res Nat Resources CIRN, P-9501801 Ponta Delgada, Azores, Portugal
[2] Univ Azores, Dept Biol, P-9501801 Ponta Delgada, Azores, Portugal
[3] Univ Porto, IBMC, P-4100 Oporto, Portugal
[4] Univ Autonoma Barcelona, Unitat Antropol Biol, Dep Biol Anim Biol Vegetal & Ecol, E-08193 Barcelona, Spain
[5] CINVESTAV IPN, Lab Nacl Genom Biodiversidad, Irapuato, Mexico
[6] Hosp D Estefania, Dept Clin Genet, Lisbon, Portugal
[7] Hosp Divino Espirito Santo, Dept Neurol, Ponta Delgada, Portugal
[8] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal
关键词
MJD; SCA3; CAG repeats; transcript variation; polyglutamine disorders; CLINICAL-FEATURES; SOMATIC MOSAICISM; AZORES ISLANDS; REPEAT; CEREBELLAR; FAMILIES; SYSTEM; MJD;
D O I
10.1038/ejhg.2009.215
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Machado-Joseph disease (MJD) is an autosomal dominant neurodegenerative disorder of late onset (occurring at a mean age of 40.2 years). The clinical manifestation of MJD is dependent on the presence of an expansion of the (CAG)(n) motif within exon 10 of the ATXN3 gene, located at 14q32.1. The variance in onset of MJD is only partially correlated (similar to 50-80%) with the extension of the CAG tract in genomic DNA (gDNA). The main aim of this work was to determine whether there are discrepancies in the size of the (CAG)(n) tract between gDNA and mRNA, and to establish whether there is a better association between age at onset and repeat size at the mRNA level. We typed gDNA and cDNA samples for the (CAG)(n) tract totalizing 108 wild-type and 52 expanded ATXN3 alleles. In wild-type alleles no differences were found between gDNA and cDNA. In expanded alleles, the CAG repeat size in gDNA was not always directly transcribed into the mRNA; on average there were differences of +1 repeat at the cDNA level. The slight discrepancies obtained were insufficient to cause significant differences in the distribution of the expanded alleles, and therefore no improvement in onset variance explanation was obtained with mRNA. European Journal of Human Genetics (2010) 18, 621-623; doi:10.1038/ejhg.2009.215; published online 25 November 2009
引用
收藏
页码:621 / 623
页数:3
相关论文
共 50 条
  • [21] Engineering isogenic neuronal models of ATXN3 knockout in Machado-Joseph Disease patient cells by CRISPR/Cas9
    Fernandes, A. R.
    Adao, D.
    Lopes, S. M.
    Henriques, D.
    Pena, F.
    Dias, M.
    Santana, M. M.
    Perdigao, P.
    Almeida, L. P.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A142 - A143
  • [22] CRISPR interference-mediated silencing of mutant ATXN3 decreases motor impairments of an in vivo Machado-Joseph disease model
    Matos, Carlos
    Pena, Frederico
    Conceicao, Andre
    Lopes, Sara
    Duarte, Sonia
    Miranda, Catarina
    de Almeida, Luis Pereira
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 : 86 - 87
  • [23] Relationship of (CAG)nC configuration to repeat instability of the Machado-Joseph disease gene
    Matsumura, R
    Takayanagi, T
    Murata, K
    Futamura, N
    Hirano, M
    Ueno, S
    HUMAN GENETICS, 1996, 98 (06) : 643 - 645
  • [24] ATXN3L: may an assumed pseudogene compensate partial loss-of-function of normal ATXN3 in Machado-Joseph disease (MJD/SCA3)?
    Costa, I. P. D.
    Lopes, A. M.
    Seixas, S.
    Sequeiros, J.
    Amorim, A.
    Martins, S.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 370 - 370
  • [25] Neurologic findings in Machado-Joseph disease -: Relation with disease duration, subtypes, and (CAG)n
    Jardim, LB
    Pereira, ML
    Silveira, I
    Ferro, A
    Sequeiros, J
    Giugliani, R
    ARCHIVES OF NEUROLOGY, 2001, 58 (06) : 899 - 904
  • [26] Genetic Variation in ATXN3 (Ataxin-3) 3′UTR: Insights into the Downstream Regulatory Elements of the Causative Gene of Machado-Joseph Disease/Spinocerebellar Ataxia Type 3
    Vieira Melo, Ana Rosa
    Raposo, Mafalda
    Ventura, Marta
    Martins, Sandra
    Pavao, Sara
    Alonso, Isabel
    Bettencourt, Conceicao
    Lima, Manuela
    CEREBELLUM, 2023, 22 (01): : 37 - 45
  • [27] Genetic Variation in ATXN3 (Ataxin-3) 3′UTR: Insights into the Downstream Regulatory Elements of the Causative Gene of Machado-Joseph Disease/Spinocerebellar Ataxia Type 3
    Ana Rosa Vieira Melo
    Mafalda Raposo
    Marta Ventura
    Sandra Martins
    Sara Pavão
    Isabel Alonso
    Conceição Bettencourt
    Manuela Lima
    The Cerebellum, 2023, 22 : 37 - 45
  • [28] Study of three intragenic polymorphisms in the Machado-Joseph disease gene (MJD1) in relation to genetic instability of the (CAG)n tract
    Patrícia Maciel
    Claudia Gaspar
    Laura Guimarães
    Jun Goto
    Iscia Lopes-Cendes
    Sean Hayes
    Karin Arvidsson
    Aureliano Dias
    Jorge Sequeiros
    Alda Sousa
    Guy A Rouleau
    European Journal of Human Genetics, 1999, 7 : 147 - 156
  • [29] Study of three intragenic polymorphisms in the Machado-Joseph disease gene (MJD1) in relation to genetic instability of the (CAG)n tract
    Maciel, P
    Gasper, C
    Guimaraes, L
    Goto, J
    Lopez-Cendes, I
    Hayes, S
    Arvidsson, K
    Dias, A
    Sequeiros, J
    Sousa, A
    Rouleau, GA
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1999, 7 (02) : 147 - 156
  • [30] Transcript Diversity of Machado–Joseph Disease Gene (ATXN3) Is Not Directly Determined by SNPs in Exonic or Flanking Intronic Regions
    Conceição Bettencourt
    Mafalda Raposo
    Raquel Ros
    Rafael Montiel
    Jácome Bruges-Armas
    Manuela Lima
    Journal of Molecular Neuroscience, 2013, 49 : 539 - 543